Skip to main content
    S

    Sonoma Pharmaceuticals Inc (SNOA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $1.18
    -0.05 (-4.07%)

    Market Cap: $5.65M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    59%(17/29)
    Avg Surprise
    +33.92%
    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 6
    		$0.02N/AN/ABeat+105.4%
    Mar 26
    Reported Jun 16
    		$-0.15N/AN/ABeat+68.7%
    Dec 25
    Reported Feb 10
    		$-0.48$-0.29-65.52%Miss+23.8%
    Sep 25
    Reported Nov 4
    		$-0.32$-0.31-3.23%Miss+45.8%
    Jun 25
    Reported Aug 7
    		$-0.37$-0.51+27.45%Beat+73.6%
    Mar 25
    Reported Jun 17
    		$-0.48$-0.04-1100.00%Miss-585.7%
    Dec 24
    Reported Feb 5
    		$-0.63$-0.60-5.00%Miss+60.6%
    Sep 24
    Reported Nov 7
    		$-0.59$-0.80+26.25%Beat+89.8%
    Jun 24
    Reported Aug 8
    		$-1.40$-0.80-75.00%Miss-400.7%
    Mar 24
    Reported Jun 17
    		$-0.07N/A+58.82%Beat+77.4%
    Dec 23
    Reported Feb 8
    		$-1.60N/A+61.90%Beat-158.1%
    Sep 23
    Reported Nov 13
    		$-5.80$-4.80-20.83%Miss-1657.6%
    Jun 23
    Reported Aug 10
    		$-0.28$-0.12-133.00%Miss+3.6%
    Mar 23
    Reported Jun 21
    		$-0.31$-0.23-34.78%Miss+0.0%
    Dec 22
    Reported Feb 14
    		$-0.62$-0.62+0.00%Beat-1450.0%
    Sep 22
    Reported Nov 14
    		$-0.33$0.00N/ABeat+36.5%
    Jun 22
    Reported Jul 13
    		$-0.29$0.00N/ABeat+44.7%
    Dec 21
    Reported Feb 11
    		$-0.31$0.00N/ABeat+3.1%
    Sep 21
    Reported Nov 15
    		$-0.04$0.00N/ABeat-166.7%
    Jun 21
    Reported Jul 14
    		$-0.52$0.00N/ABeat-196.3%
    Mar 21
    Reported Jun 30
    		$-0.52$0.00N/AMiss-36.1%
    Dec 20
    Reported Feb 16
    		$-0.32N/A+55.56%Beat-102.5%
    Sep 20
    Reported Nov 20
    		$0.06N/A+105.08%Beat+100.3%
    Jun 20
    Reported Jul 10
    		$0.54$-0.91+159.34%Beat+102.0%
    Mar 20
    Reported Jun 30
    		$-0.39$0.00N/ABeat+74.6%
    Dec 19
    Reported Feb 14
    		$12.72$-0.72+1866.67%Beat+127.2%
    Sep 19
    Reported Nov 14
    		$-18.20$-23.60+22.88%Beat+77.0%
    Jun 19
    Reported Jul 8
    		$-26.70$-35.80+25.42%Beat+73.0%
    Mar 19
    Reported Jun 30
    		$-1.52$-2.12+28.30%Beat+81.8%
    Dec 18
    Reported Feb 14
    		$-46.80$-60.30+22.39%Beat+64.4%
    Sep 18
    Reported Nov 8
    		$-79.20$-81.90+3.30%Beat+34.3%
    Jun 18
    Reported Aug 8
    		$-99.00$-95.40-3.77%Miss+32.9%
    Mar 18
    Reported Jun 13
    		$-8.37$-5.28-58.52%Miss-63.2%
    Dec 17
    Reported Feb 7
    		$-131.40$-111.00-18.38%Miss-117.8%
    Sep 17
    Reported Nov 9
    		$-120.60$-124.20+2.90%Beat-
    Jun 17
    Reported Aug 8
    		$-147.60$-131.40-12.33%Miss-
    Mar 17
    Reported Jun 5
    		$-5.13$-6.03+14.93%Beat-
    Dec 16
    Reported Feb 9
    		$736.56$554.40+32.86%Beat-

    Key Metrics

    Valuation
    P/E Ratio-1.27EV/EBITDAN/A
    Price/FCF-1.71xFCF Yield-58.50%
    Profitability
    Profit Margin-10.30%Operating Margin-0.62%
    ROE-42.50%ROIC-33.62%
    Financial Health
    Debt/Equity0.02xInterest CoverageN/A
    Current Ratio2.99xQuick Ratio2.29x
    Trading Statistics
    Beta1.30Avg Volume48.09K
    52-Week High$4.1052-Week Low$0.85

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.22
    SMA 20$1.24
    SMA 50$1.28
    SMA 200$1.86
    EMA 10$1.22
    EMA 20$1.24
    EMA 50$1.26
    EMA 200$1.78

    MACD

    Line: -0.02Signal: -0.02Hist: -0.01

    ADX

    ADX: 15.2+DI: 18.4-DI: 22.7

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down88.0
    PSAR$1.14

    Bollinger Bands

    Upper Band$1.31
    Lower Band$1.18
    %B Position1031%(Upper)
    Band Width0.02

    RSI (14-Day)

    Neutral
    40.7

    Momentum Oscillators

    Stoch %K43.1
    Stoch %D36.2
    Williams %R-76.5
    ROC (10d)-5.2%
    Momentum-0.07
    CCI (20d)-144.1
    MFI (14d)46.0

    Volatility Measures

    ATR (14d)$0.06(5.3%)
    StdDev (20d)0.03
    Hist Vol45.0%(High)

    Volume Flow

    VWAP$1.20
    OBV134.8M
    AD Line-22.2M
    CMF (20d)-0.260

    Volume Metrics

    Avg Vol (20d)48.2K
    Vol Ratio1.0x
    VWMA (20d)$1.24

    Pivot Points

    R3$1.34
    R2$1.32
    R1$1.27
    Pivot Point$1.25
    S1$1.20
    S2$1.18
    S3$1.13

    Advanced Oscillators

    TSI-12.08
    Ultimate Osc36.2
    KST-60.16

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$6.41M$5.56M$4.35M$5.60M$4.01M$3.75M$3.56M$3.58M$3.39M$3.44M$3.14M$2.73M
    Cost of Revenue$3.83M$3.38M$2.70M$3.48M$2.55M$2.23M$2.29M$2.22M$2.08M$2.35M$1.68M$1.74M
    Gross Profit$2.58M$2.18M$1.65M$2.12M$1.46M$1.53M$1.27M$1.36M$1.31M$1.09M$1.46M$990,000
    Operating Expenses$2.62M$2.53M$2.33M$2.46M$2.56M$2.18M$2.30M$2.21M$2.48M$2.50M$2.30M$2.20M
    R&D$597,000$545,000$557,000$575,000$594,000$411,000$427,000$506,000$470,000$409,000$601,000$536,000
    SG&A$2.02M$1.99M$1.77M$1.88M$1.97M$1.77M$1.87M$1.71M$2.01M$2.09M$1.70M$1.66M
    Operating Income$-40,000$-351,000$-678,000$-337,000$-1,095,000$-656,000$-1,031,000$-850,000$-1,173,000$-1,409,000$-844,000$-1,208,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$290,000$146,000$271,000$394,000$147,000$0$0$0$0$0$79,000$90,000
    Income Before Tax$-330,000$-497,000$-949,000$-731,000$-1,242,000$-528,000$-919,000$-463,000$-997,000$-1,359,000$-923,000$-1,298,000
    Income Tax Expense$0$84,000$-130,000$-197,000$-1,000$248,000$9,000$147,000$146,000$-292,000$-57,000$186,000
    Net Income$-330,000$-581,000$-819,000$-534,000$-1,241,000$-776,000$-928,000$-610,000$-1,143,000$-1,067,000$-866,000$-1,484,000
    EBITDA$-298,000$-464,000$-915,000$-695,000$-1,206,000$-497,000$-886,000$-428,000$-958,000$-1,318,000$-878,000$-1,253,000
    EBIT$-330,000$-497,000$-949,000$-731,000$-1,242,000$-528,000$-919,000$-463,000$-997,000$-1,359,000$-923,000$-1,298,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SNOA

    News

    SNOA Forecast — Price Target — Prediction for 2027

    This article provides a forecast and price target for Sonoma Pharmaceuticals, Inc. (SNOA) up to 2027. It includes current stock performance metrics, historical highs and lows, volatility, market capitalization...

    TradingView•9/30/26•Somewhat-Bearish

    O8Z Forecast — Price Target — Prediction for 2027

    This article provides key financial data and forecasts for Sonoma Pharmaceuticals, Inc. (O8Z) traded on the Frankfurt Stock Exchange. It covers historical stock prices, upcoming earnings reports...

    TradingView•9/30/26•Neutral

    Price to book forward of Sonoma Pharmaceuticals, Inc. – MUN:O8Z

    This article provides financial data for Sonoma Pharmaceuticals, Inc. (MUN:O8Z) focusing on its price-to-book forward ratio. It appears to be a data point from TradingView...

    TradingView•8/22/26•Neutral

    Sonoma Pharmaceuticals cancels special meeting due to lack of quorum

    Sonoma Pharmaceuticals (NASDAQ:SNOA) announced the cancellation of its adjourned special meeting of stockholders because a quorum was not reached. The meeting...

    Investing.com•8/20/26•Somewhat-Bearish

    Sonoma Pharmaceuticals cancels special meeting due to lack of quorum By Investing.com

    Sonoma Pharmaceuticals announced the cancellation of its adjourned special meeting of stockholders due to a lack of quorum...

    Investing.com South Africa•8/19/26•Neutral

    SNOA Valuation and Fair Value

    P/E
    -1.3x
    Forward P/E
    46.1x
    P/FCF
    -1.7x
    PEG
    1.1x
    P/B
    0.7x
    See GNG's fair value

    SNOA Profitability: Margins, ROIC and FCF

    Gross margin
    38.9%
    Operating margin
    -0.6%
    Net margin
    -10.3%
    ROIC
    -33.6%
    ROE
    -42.5%
    FCF margin
    -12.1%
    FCF yield
    -58.5%

    SNOA Competitors

    CompanyTicker
    Imunon IncIMNN
    enVVeno Medical CorpNVNO
    Can Fite Biopharma Ltd ADRCANF
    Longeveron LLCLGVN
    EvogeneEVGN
    Scienture Holdings, Inc.SCNX
    Lexaria Bioscience CorpLEXX
    Volitionrx LtdVNRX

    Sector: Healthcare

    SNOA Bull Case vs Bear Case

    Bull case

    • SNOA grew quarterly revenue 59.6% year over year.

    Bear case

    • SNOA has a -10.3% net profit margin.
    • SNOA beat EPS estimates in 37.5% of its last 8 reported quarters.

    SNOA Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -170.7%

    Frequently Asked Questions About SNOA

    Does SNOA pay dividends?

    Sonoma Pharmaceuticals Inc (SNOA) does not currently pay a regular dividend.

    What is SNOA's market cap?

    Sonoma Pharmaceuticals Inc (SNOA) has a market capitalization of $5.65M with a current stock price of $1.18.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In